Figures computed from official regulatory filings — .
Ownershipinsiders 34.76% · institutions 35.46%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for SENSORION only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France.
Market information source · Oct 19, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| REDMILE BIOPHARMA INVESTMENTS III | Award | $6.3M | AMF |
| Sofinnova Partners SAStrack record | Award | $3.6M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Award | $1.9M | AMF |
| Sofinnova Partners SAStrack record | Award | $1.1M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Award | $10.3M | AMF |
| Sofinnova Partners SAStrack record | Award | $7.5M | AMF |
| INVUS | Sell | $30.7M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | AwardD (derivative) | $3.5M | AMF |
| REDMILE BIOPHARMA INVESTMENTS III | Award | $14.2M | AMF |
| Sofinnova Partners SAStrack record | Award | $7.7M | AMF |
| Sofinnova Partners SAStrack record | Award | $2.7M | AMF |
| Sofinnova Partners SAStrack record | Award | $7.2M | AMF |
| Sofinnova Partners SAStrack record | AwardD (derivative) | $8.5M | AMF |
| Sofinnova Partners SAStrack record | OtherD (derivative) | $8.2M | Unusual size | AMF |